Client News

Vivoryon Therapeutics AG to Publish its Half Year 2019 Results on August 29, 2019

Adrenomed Supervisory Board appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, joins the Executive Board

MagForce AG: MagForce USA, Inc. Completed Enrollment and Treatment for Stage 1 and Prepares for Next Stage of its Pivotal, Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with NanoTherm Therapy

Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

Adocia announces that the American Arbitration Association Tribunal dismissed all claims in second phase of arbitration with Eli Lilly

Vivoryon Therapeutics AG to Publish its Half Year 2019 Results on August 29, 2019

Ergomed plc: Ian Johnson Appointed as Non-Executive Director

First patient enrolled in Abivax ABX464-103 Phase 2b Clinical Trial in Patients with Ulcerative Colitis

NIH to Evaluate Iclaprim Activity against Listeria

InflaRx reports second quarter 2019 financial & operating results